Lifecome Biochemistry Co.,Ltd. (SHE:002868)

Lifecome Biochemistry Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Equivalents	51.4	55.6	24.8	84.38	23.76	97.5
Cash & Short-Term Investments	51.4	55.6	24.8	84.38	23.76	97.5
Cash Growth	223.61%	124.20%	-70.61%	255.14%	-75.63%	-49.81%
Accounts Receivable	48.5	42.64	76.83	128.42	60.06	44.86
Other Receivables	7.86	9.35	17.52	59.82	2.76	19.56
Receivables	56.36	51.99	94.36	188.24	62.82	64.42
Inventory	90.34	95.48	95.71	201.89	89.06	61.2
Other Current Assets	1.38	4.62	1.36	3.87	330.16	4.86
Total Current Assets	199.48	207.68	216.22	478.39	505.8	227.97
Property, Plant & Equipment	463.03	474.44	1,062	1,150	633.54	907.87
Long-Term Investments	29.42	32.46	51.65	44.75	48.57	59.14
Goodwill	-	-	-	61.6	-	-
Other Intangible Assets	21.08	21.08	125.58	132.21	31.4	40.86
Long-Term Deferred Tax Assets	11.3	11.42	11.05	30.96	7.47	9.15
Long-Term Deferred Charges	-	0.02	12.49	0.8	0.19	2.03
Other Long-Term Assets	4.84	1.62	12.49	66.79	12.9	11.39
Total Assets	729.16	748.71	1,492	1,965	1,240	1,258

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Accounts Payable	88.85	102.52	315.72	310.09	136.11	167.7
Accrued Expenses	6.14	7.2	17.12	12.56	7.95	9.79
Short-Term Debt	314.22	306.72	296.76	387.77	202.93	156.28
Current Portion of Long-Term Debt	130	170.83	479.08	85.47	41.71	37.16
Current Portion of Leases	-	-	4.36	1.31	0.08	0.07
Current Unearned Revenue	3.31	4.92	17.06	1.51	2.81	0.91
Other Current Liabilities	3.88	5.05	112.6	131.61	93.54	18.42
Total Current Liabilities	546.39	597.24	1,243	930.31	485.14	390.34
Long-Term Debt	25	30	133.92	490.25	105.88	96.99
Long-Term Leases	-	-	35.47	121.9	45	30.69
Long-Term Unearned Revenue	1.73	1.94	30.02	3.47	4.32	9.63
Long-Term Deferred Tax Liabilities	-	-	3.46	4.96	0.22	8.73
Other Long-Term Liabilities	83.68	54.6	70.63	-	-	-
Total Liabilities	656.81	683.78	1,516	1,551	640.56	536.38

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Common Stock	155.42	155.42	155.42	155.42	155.42	155.42
Additional Paid-In Capital	576.97	576.51	349.47	345.46	340.47	340.47
Retained Earnings	-661.84	-669.15	-538.36	-93.5	128.32	250.26
Treasury Stock	-	-	-	-	-32.43	-32.43
Comprehensive Income & Other	0.41	0.41	7.2	3.91	3.91	3.91
Total Common Equity	70.95	63.18	-26.27	411.29	595.69	717.63
Minority Interest	1.4	1.75	1.73	2.82	3.61	4.4
Shareholders' Equity	72.35	64.93	-24.54	414.11	599.3	722.02
Total Liabilities & Equity	729.16	748.71	1,492	1,965	1,240	1,258

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Total Debt	469.22	507.55	949.6	1,087	395.6	321.19
Net Cash (Debt)	-417.82	-451.94	-924.8	-1,002	-371.84	-223.7
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.70	-2.92	-5.95	-6.51	-2.41	-1.46
Filing Date Shares Outstanding	155.42	155.42	155.42	155.42	153.4	153.4
Total Common Shares Outstanding	155.42	155.42	155.42	155.42	153.4	153.4
Working Capital	-346.9	-389.55	-1,026	-451.92	20.66	-162.36
Book Value Per Share	0.46	0.41	-0.17	2.65	3.88	4.68
Tangible Book Value	49.87	42.1	-151.84	217.48	564.29	676.77
Tangible Book Value Per Share	0.32	0.27	-0.98	1.40	3.68	4.41
Buildings	388.09	388.09	543.18	479.28	406.53	206.45
Machinery	577.87	579.72	890.18	657.2	585.29	310.2
Construction In Progress	17.43	5.52	55.9	410.78	6.2	709.64

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error